Galectin Therapeutics Inc (GALT)

1.15 +0.28 (+32.17%) USD  |  NASDAQ  |  Dec 27, 16:00
1.13 -0.02 (-1.74%) After-Hours: 20:00
More

Galectin Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Alaunos Therapeutics Inc Upgrade
SELLAS Life Sciences Group Inc Upgrade
Oragenics Inc Upgrade
Anavex Life Sciences Corp Upgrade
Phathom Pharmaceuticals Inc Upgrade